- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Philips Set to Showcase AI-Based Solutions at Arab Health 2020
Company highlights CT, image-guided therapy, and enterprise imaging solutions.
DUBAI – Philips Healthcare is set to highlight several product offerings during the Arab Health 2020 annual meeting.
During the conference, the company will present its artificial intelligence (AI)-based solutions intended to improve patient care and care delivery. The overall goal, according to company information, is to develop integrated solutions that can adapt to customer needs and embed into individual workflows.
Over the next few days, conference attendees will have the opportunity review these Philips products:
- Azurion with FlexArm: This gantry development on Philips’ Azurion platform adds new imaging and patient positioning opportunities. It includes a set of innovations that facilitates performing 2D and 3D imaging across the whole patient.
- IQon Elite Spectral CT: As the industry’s only spectral detector-based CT system, it pairs conventional CT images with layers of spectral results in the same exam, potentially reducing the cost associated with repeat exams.
In addition, the company will showcase:
- Next-generation enterprise imaging informatics, including a suite of integrated products with a comprehensive platform designed to connect clinical capabilities and optimize workflows
- PerformanceBridge, Philips’ vendor-agnostic, integrated, scalable portfolio of analytics, services, and tools that gives hospital departments real-time information for performance improvement
New Study Examines Short-Term Consistency of Large Language Models in Radiology
November 22nd 2024While GPT-4 demonstrated higher overall accuracy than other large language models in answering ACR Diagnostic in Training Exam multiple-choice questions, researchers noted an eight percent decrease in GPT-4’s accuracy rate from the first month to the third month of the study.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
FDA Clears Updated AI Platform for Digital Breast Tomosynthesis
November 12th 2024Employing advanced deep learning convolutional neural networks, ProFound Detection Version 4.0 reportedly offers a 50 percent improvement in detecting cancer in dense breasts in comparison to the previous version of the software.
